Suppr超能文献

美国骨Paget病中的泛素结合蛋白1(SQSTM1)突变

Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States.

作者信息

Rhodes Emily C, Johnson-Pais Teresa L, Singer Frederick R, Ankerst Donna P, Bruder Jan M, Wisdom Julie, Hoon Dave S B, Lin Emerald, Bone Henry G, Simcic Kenneth J, Leach Robin J

机构信息

Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

出版信息

Calcif Tissue Int. 2008 Apr;82(4):271-7. doi: 10.1007/s00223-008-9114-9. Epub 2008 Apr 1.

Abstract

Paget's disease of bone (PDB) is a localized bone disease characterized by excessive bone resorption due to overactive osteoclasts. Seven genetic loci (PDB1-PDB7) have been reported for late-onset PDB. PDB3 is the only locus where a gene, sequestosome 1 (SQSTM1), has been identified. Mutations in SQSTM1 have been associated with both sporadic and hereditary PDB in different populations. However, the SQSTM1 mutation frequency in PDB patients from a more heterogeneous population has never been reported. To investigate this, we determined the frequency of mutations in patients from the United States. Blood was collected from sporadic and hereditary PDB patients in the United States. DNA was isolated from whole blood or from serum. The SQSTM1 sequence was determined for exons and intron/exon junctions from whole blood and serum. A total of 112 (39 hereditary, 73 sporadic) samples were collected. Eight mutations were found in hereditary PDB patients, for a mutation frequency of 20.5% (95% confidence interval [CI] 10.8-35.5%) and did not differ significantly from mutation rates observed in studies in Canada, Great Britain, and The Netherlands. No mutations were found in sporadic patients, for a frequency of 0% (95% CI 0.0-5.0%), which was statistically significantly lower than the mutation rates previously observed in populations from Australia (P = 0.009), Canada (P = 0.008), Great Britain (P = 0.02), and France (P = 0.04) but not compared to rates from Belgium, The Netherlands, and Italy. Four out of five families with the P392L mutation carried it on the H2 haplotype. Mutations in SQSTM1 seem to contribute to the pathogenesis of PDB in hereditary, but not sporadic, patients in the United States.

摘要

骨佩吉特病(PDB)是一种局限性骨病,其特征是破骨细胞过度活跃导致骨吸收过多。已报道了7个与晚发型PDB相关的基因位点(PDB1 - PDB7)。PDB3是唯一已鉴定出基因(聚集体蛋白1,SQSTM1)的位点。在不同人群中,SQSTM1突变与散发性和遗传性PDB均有关联。然而,来自更多样化人群的PDB患者中SQSTM1突变频率从未被报道过。为了对此进行研究,我们测定了美国患者的突变频率。收集了美国散发性和遗传性PDB患者的血液。从全血或血清中分离DNA。测定了全血和血清中SQSTM1基因外显子以及内含子/外显子连接区的序列。总共收集了112份样本(39份遗传性样本,73份散发性样本)。在遗传性PDB患者中发现了8个突变,突变频率为20.5%(95%置信区间[CI] 10.8 - 35.5%),与在加拿大、英国和荷兰的研究中观察到的突变率无显著差异。在散发性患者中未发现突变,频率为0%(95% CI 0.0 - 5.0%),这在统计学上显著低于先前在澳大利亚(P = 0.009)、加拿大(P = 0.008)、英国(P = 0.02)和法国(P = 0.04)人群中观察到的突变率,但与比利时、荷兰和意大利的突变率相比无差异。携带P392L突变的5个家族中有4个家族的该突变位于H2单倍型上。在美国,SQSTM1突变似乎在遗传性而非散发性PDB患者的发病机制中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验